Annals of Hepato-Biliary-Pancreatic Surgery

Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN 2508-5859   pISSN 2508-5778

Table. 3.

Table. 3.

Univariate and multivariate analyses of factors influencing overall survival

p univariate Hazard ratio p multivariate
Synchronous disease 0.28 -
Primary tumor location 0.42 -
Serum CEA level 0.12 -
S-CLM location (right- versus left-sided) 0.03 1.92 [1.01-3.65] 0.04
Neoadjuvant chemotherapy 0.07 1.54 [0.74-3.21] 0.25
Surgical approach 0.38 -
S-CLM size 0.42 -
R1 resection margin 0.68 -
KRAS mutation 0.07 3.97 [1.54-10.2] <0.01
Adjuvant chemotherapy 0.76 -
Hepatic recurrence 0.23 -
Extra-hepatic recurrence <0.01 9.18 [1.97-42.9] <0.01

CEA, carcinoembryonic antigen; S-CLM, solitary colorectal liver metastasis

Ann Hepatobiliary Pancreat Surg 2021;25:198-205 https://doi.org/10.14701/ahbps.2021.25.2.198
© 2021 Ann Hepatobiliary Pancreat Surg